Risk of CIN 3+ in HPV+ Women with Normal Cytology and 5 year Type Concordance (Publication)

A new publication of the RISCC consortium is published online ahead of print in Cancer Epidemiology, Biomarkers & Prevention. The study aims to demonstrate the potential of 5-year HPV type concordance as a disease marker for HPV-positive and cytology-negative women. First author is Federica Inturrisi. The full manuscript can be found here. A visual summary of the study can be found below.

lightbox

Consortium meeting (December 9th)

On Wednesday December 9th 2020, the RISCC Consortium had their second biannual meeting. Due to current restrictions in many European countries the meeting was held completely online. During a very productive and inspiring meeting the members of the Consortium received an update on the current progress.

Figure 2.png

Figure 3.png

Interview Prof. Berkhof

The RISCC project coordinator Prof. Berkhof was interviewed by ZonMW. The article is in Dutch and can be found here: "It can be cheaper and more effective"

Direct effect of HPV vaccination on lifetime risk of precancer (Publication)

A new publication of the RISCC consortium was published this summer in the International Journal of Cancer. This research study conducted by Federica Inturrisi and colleagues aims to estimate the lifetime risk of (screen-detected) CIN2+ and CIN3+, using the using the Populationā€based Screening Study Amsterdam (POBASCAM). The full manuscript can be found here. A visual summary of the study can be found below.

Lightbox